Biosyent Inc (BIOYF)
7.49
-0.13
(-1.71%)
USD |
OTCM |
Jun 28, 16:00
Biosyent Max Drawdown (5Y): 74.65% for May 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
May 31, 2024 | 74.65% |
April 30, 2024 | 74.65% |
March 31, 2024 | 74.65% |
February 29, 2024 | 74.65% |
January 31, 2024 | 74.65% |
December 31, 2023 | 74.65% |
November 30, 2023 | 74.65% |
October 31, 2023 | 74.65% |
September 30, 2023 | 74.65% |
August 31, 2023 | 74.65% |
July 31, 2023 | 74.65% |
June 30, 2023 | 74.65% |
May 31, 2023 | 74.65% |
April 30, 2023 | 74.65% |
March 31, 2023 | 74.65% |
February 28, 2023 | 74.65% |
January 31, 2023 | 74.65% |
December 31, 2022 | 74.65% |
November 30, 2022 | 74.65% |
October 31, 2022 | 74.65% |
September 30, 2022 | 74.65% |
August 31, 2022 | 74.65% |
July 31, 2022 | 74.65% |
June 30, 2022 | 74.65% |
May 31, 2022 | 74.65% |
Date | Value |
---|---|
April 30, 2022 | 74.65% |
March 31, 2022 | 74.65% |
February 28, 2022 | 74.65% |
January 31, 2022 | 74.65% |
December 31, 2021 | 74.65% |
November 30, 2021 | 74.65% |
October 31, 2021 | 74.65% |
September 30, 2021 | 74.65% |
August 31, 2021 | 74.65% |
July 31, 2021 | 74.65% |
June 30, 2021 | 74.65% |
May 31, 2021 | 74.65% |
April 30, 2021 | 74.65% |
March 31, 2021 | 74.65% |
February 28, 2021 | 74.65% |
January 31, 2021 | 74.65% |
December 31, 2020 | 74.65% |
November 30, 2020 | 74.65% |
October 31, 2020 | 74.65% |
September 30, 2020 | 74.65% |
August 31, 2020 | 74.65% |
July 31, 2020 | 74.65% |
June 30, 2020 | 74.65% |
May 31, 2020 | 74.65% |
April 30, 2020 | 74.65% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
63.25%
Minimum
Jun 2019
74.65%
Maximum
Mar 2020
72.94%
Average
74.65%
Median
Mar 2020
Max Drawdown (5Y) Benchmarks
Acasti Pharma Inc | 98.73% |
Aurinia Pharmaceuticals Inc | 87.58% |
Edesa Biotech Inc | 99.58% |
Lexaria Bioscience Corp | 98.90% |
Xenon Pharmaceuticals Inc | 64.74% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -9.265 |
Beta (5Y) | 0.8085 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 33.99% |
Historical Sharpe Ratio (5Y) | 0.0534 |
Historical Sortino (5Y) | 0.0732 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 12.99% |